The Department of Radiation Oncology conducts prospective, phase I-III clinical trials involving radiotherapy as combined or single modality treatment in breast, lung, urology, gynaecological, gastrointestinal, head and neck, neurology and skin cancers.
The Department of Radiation Oncology is experienced in running clinical trials in stereotactic ablative body radiotherapy, brachytherapy, intensity-modulated radiation therapy and combinations of radiotherapy with chemotherapy, immunotherapy and targeted therapies and trials involving advanced medical imaging techniques.
To approach Radiation Oncology Trials with a potential clinical trial, email through:
- Mutual Confidentiality Agreement in editable word format (if required)
- Protocol or synopsis
- Number of sites
- Number of participants
To the Radiation Oncology Research Manager.
Radiation Oncology Research Manager
Phone +61 3 8559 8481